Public Health England has been monitoring the effectiveness of vaccinations in clinical risk groups with immunosuppression, which includes recipients of solid organ transplants. From the evaluation of the vaccine programme, the data shows that completion of the two dose schedule correlates well with protection from both disease and severe outcomes, including hospitalisation and death.<\/p>
<\/p>
Virus Watch, supported by the UK Research and Innovation and National Institute for Health Research COVID-19 Rapid Response initiative and NHS Test and Trace, provided information regarding patients\u2019 antibodies and included immunocompromised patients as part of their cohort. This suggests some protection against COVID-19 but is only one measure of protection and excludes cellular immunity.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"} } , "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"} , "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"} , "dateOfAnswer" : {"_value" : "2021-09-06", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2021-09-06T11:24:59.177Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2021-07-21", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Coronavirus: Vaccination"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the efficacy of covid-19 vaccines for recipients of solid organ transplants.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4491", "label" : {"_value" : "Biography information for Vicky Foxcroft"} } , "tablingMemberConstituency" : {"_value" : "Lewisham, Deptford"} , "tablingMemberPrinted" : [{"_value" : "Vicky Foxcroft"} ], "uin" : "37534"} , {"_about" : "http://data.parliament.uk/resources/1347747", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1347747/answer", "answerText" : {"_value" : "
The Joint Committee on Vaccination and Immunisation (JCVI) published interim advice on a potential COVID-19 booster vaccination programme on 30 June, which is available at the following link:<\/p>
<\/p>
https://www.gov.uk/government/publications/uk-5-year-action-plan-for-antimicrobial-resistance-2019-to-2024 <\/a><\/p> <\/p> The JCVI advises a two staged approach, with individuals in stage one offered a booster and flu vaccine as soon as possible from September. Individuals in stage two should be offered a booster vaccine as soon as practicable after stage one, with equal emphasis on deployment of the flu vaccine where eligible. The JCVI suggests that adults aged 16 years old and over who are immunosuppressed are offered a booster vaccine in stage one.<\/p> <\/p> Final decisions on the timing and scope and cohort eligibility of any COVID-19 vaccine booster\u202fprogramme will be confirmed once the JCVI has provided their final advice.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"}
}
, "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"}
, "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"}
, "dateOfAnswer" : {"_value" : "2021-07-26", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2021-07-26T16:15:40.097Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2021-07-16", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Coronavirus: Vaccination"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, when his Department plans to offer people who are immunosuppressed, but not identified as extremely clinically vulnerable, a booster covid-19 vaccination as part of the covid-19 vaccination booster programme.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4491", "label" : {"_value" : "Biography information for Vicky Foxcroft"}
}
, "tablingMemberConstituency" : {"_value" : "Lewisham, Deptford"}
, "tablingMemberPrinted" : [{"_value" : "Vicky Foxcroft"}
], "uin" : "34548"}
, {"_about" : "http://data.parliament.uk/resources/1339514", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1339514/answer", "answerText" : {"_value" : " The Virus Watch study, supported by NHS Test and Trace, shows a modestly reduced antibody response after one COVID-19 vaccine dose among individuals with immunosuppression, including those on immunosuppressive therapy. However, this is not a direct measure of protection and it is still early to determine impact on clinical disease or whether the antibody response remains after a complete course of vaccination.<\/p> <\/p> Shielding was paused on 1 April 2021. Clinically extremely vulnerable people are advised to take the extra precautions provided by the Government to reduce their chance of infection and must continue to follow the current regulations.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"}
}
, "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"}
, "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"}
, "dateOfAnswer" : {"_value" : "2021-06-29", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2021-06-29T15:24:13.71Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2021-06-23", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Coronavirus: Vaccination"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the effect of immunosuppressive medication on the effectiveness of covid-19 vaccinations; and whether those living with inflammatory immune-mediated conditions taking such medication should be advised to shield as a result.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4491", "label" : {"_value" : "Biography information for Vicky Foxcroft"}
}
, "tablingMemberConstituency" : {"_value" : "Lewisham, Deptford"}
, "tablingMemberPrinted" : [{"_value" : "Vicky Foxcroft"}
], "uin" : "21289"}
, {"_about" : "http://data.parliament.uk/resources/1305297", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1305297/answer", "answerText" : {"_value" : " We do not hold data on vaccination totals by specific medical condition, such as cystic fibrosis or other respiratory conditions.<\/p> NHS England and NHS Improvement do provide a weekly breakdown of data on vaccinations administered to clinically extremely vulnerable people. This information is updated on Thursdays, and can be found at the following link:<\/p>